Erlotinib ve 4. linii léčby nemalobuněčného plicního karcinomu.
Authors | |
---|---|
Year of publication | 2013 |
Type | Article in Periodical |
Magazine / Source | Farmakoterapie |
Citation |
Authors | |
---|---|
Year of publication | 2013 |
Type | Article in Periodical |
Magazine / Source | Farmakoterapie |
Citation |